Overview
- 14 inspections across 14 sites are on record.
- 46 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-01-30.
At a glance
Inspections
14
Sites
14
Observations
46
Career since
Sep 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Allergan Pharmaceuticals Ireland | 30 Jan 2025 | Human Drugs | On file |
| Center for Instrumental Analysis of China Pharmaceutical University | 20 Sep 2024 | Human Drugs | View 483 → |
| China Pharmaceutical University | 20 Sep 2024 | Human Drugs | View 483 → |
| Simcere Pharmaceutical Co., Ltd. | 13 Sep 2024 | Human Drugs | |
| Wisdom Pharmaceutical Co., Ltd. | 6 Sep 2024 | Human Drugs |
Sites inspected
Allergan Pharmaceuticals IrelandWestport, Ireland1 insp.
Center for Instrumental Analysis of China Pharmaceutical UniversityNanjing, China1 insp.
China Pharmaceutical UniversityNanjing, China1 insp.
Simcere Pharmaceutical Co., Ltd.Nanjing, China1 insp.
Wisdom Pharmaceutical Co., Ltd.Haimen, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Shelby N Turner4 shared
Marcellinus D Dordunoo3 shared
Jie He1 shared
Thuy T Nguyen1 shared
Taichun Qin1 shared
Jazmine N Brown1 shared
Yvins Dezan1 shared
Monica C Burgos Garcia1 shared
Rebecca E Dombrowski1 shared
Patric C Klotzbuecher1 shared
Full investigator report
Get the verbatim findings behind Kejun Cheng's 46 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site